Published in Medical Letter on the CDC and FDA, December 14th, 2003
In November, the company announced the Independent Investigational Review board (IRB) has unanimously approved all aspects of the research protocol and the testing will start immediately in medical clinics in south Florida, and will be supervised by physicians.
The IRB is an institutional review committee structured in compliance with the regulations of the U.S. Food and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.